U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07916194) titled 'A Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy Participants' on Oct. 29.
Brief Summary: This study is a single-dose, open-label, non-randomized, parallel design phase I clinical study to evaluate the PK characteristics and safety of single subcutaneous injection of ZT002 Injection in participants with varying degrees of Hepatic Impairment and matched participants with normal hepatic function.
Study Start Date: Nov. 13
Study Type: INTERVENTIONAL
Condition:
Overweight, Obesity
Intervention:
DRUG: Zovaglutide
All subjects will be treated with a single subcutaneous injection of Zovaglu...